In addition, 27% of carriers of the BRCA1 pathogenic variant and 19% of carriers of the BRCA2 pathogenic variant will develop a second primary contralateral breast cancer within 10 years after the first primary breast cancer diagnosis [7]. The gene discussed is BRCA2; the disease is breast carcinoma.